Skip to main content

Peer Review reports

From: A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial

Original Submission
11 Sep 2020 Submitted Original manuscript
14 Sep 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
16 Sep 2020 Editorially accepted
2 Oct 2020 Article published 10.1186/s13063-020-04746-9

You can find further information about peer review here.

Back to article page